M Araujo-Castro1, E Pascual-Corrales2, V Martínez-Vaello2, G Baonza Saiz2, J Quiñones de Silva2, A Acitores Cancela3, A M García Cano4, V Rodríguez Berrocal3,5. 1. Neuroendocrinology Unit, Department of Endocrinology and Nutrition, Hospital Universitario Ramón y Cajal, Madrid, Spain. martaazul.2a@hotmail.com. 2. Neuroendocrinology Unit, Department of Endocrinology and Nutrition, Hospital Universitario Ramón y Cajal, Madrid, Spain. 3. Neuroendocrinology Unit, Department of Neurosurgery, Hospital Universitario Ramón y Cajal, Madrid, Spain. 4. Hormones and Tumors Markers Unit, Department of Biochemistry, Hospital Universitario Ramón y Cajal, Madrid, Spain. 5. Endoscopic Skull Base Unit, Department of Neurosurgery, Hospital Universitario HM Puerta del Sur, Madrid, Spain.
Abstract
PURPOSE: To identify presurgical clinical, hormonal and radiological variables associated with surgical remission in acromegaly and develop a predictive model for surgical remission. METHODS: Ambispective study of acromegaly surgical patients followed in two Spanish tertiary hospitals. Patients operated by the same neurosurgeon by endonasal endoscopic transsphenoidal approach (n = 49) were included to develop the predictive model, and patients operated by other neurosurgeons (n = 37) were used for external validation of the predictive model. The predictive model was developed with a multivariate logistic regression model based on the 2000 criteria. RESULTS: 86 acromegalic patients were included. 49 patients, 83.7% with macroadenomas and 32.7% with Knosp grade > 2, were included for the development of the predictive model. The overall rate of surgical remission with the 2000 criteria was 73.5% and 51.0% with the 2010 criteria. Using the 2000 criteria, variables associated with surgical remission were: older age (OR = 1.1, p = 0.001), lower basal presurgical GH levels (OR = 0.9, p = 0.003), Knosp 0-2 (OR = 34.1, p < 0.0001) and lower maximum pituitary adenoma diameter (OR = 0.9, p = 0.019). The model with the best diagnostic accuracy to predict surgical remission combined age, Knosp 0-2 and presurgical GH levels (AIC = 29.7, AUC = 0.95) with a sensitivity of 93.8% and a specificity of 75.0%. The estimated loss of prediction with the external validation (n = 37) was 4.2%. CONCLUSION: The predictive model with the best diagnosis accuracy for surgical remission combined age, Knosp 0-2 and presurgical GH levels, with a sensitivity of 93.8% and a specificity of 75.0%. This model could be very useful to select candidates to preoperative medical treatment and planning the follow-up.
PURPOSE: To identify presurgical clinical, hormonal and radiological variables associated with surgical remission in acromegaly and develop a predictive model for surgical remission. METHODS: Ambispective study of acromegaly surgical patients followed in two Spanish tertiary hospitals. Patients operated by the same neurosurgeon by endonasal endoscopic transsphenoidal approach (n = 49) were included to develop the predictive model, and patients operated by other neurosurgeons (n = 37) were used for external validation of the predictive model. The predictive model was developed with a multivariate logistic regression model based on the 2000 criteria. RESULTS: 86 acromegalicpatients were included. 49 patients, 83.7% with macroadenomas and 32.7% with Knosp grade > 2, were included for the development of the predictive model. The overall rate of surgical remission with the 2000 criteria was 73.5% and 51.0% with the 2010 criteria. Using the 2000 criteria, variables associated with surgical remission were: older age (OR = 1.1, p = 0.001), lower basal presurgical GH levels (OR = 0.9, p = 0.003), Knosp 0-2 (OR = 34.1, p < 0.0001) and lower maximum pituitary adenoma diameter (OR = 0.9, p = 0.019). The model with the best diagnostic accuracy to predict surgical remission combined age, Knosp 0-2 and presurgical GH levels (AIC = 29.7, AUC = 0.95) with a sensitivity of 93.8% and a specificity of 75.0%. The estimated loss of prediction with the external validation (n = 37) was 4.2%. CONCLUSION: The predictive model with the best diagnosis accuracy for surgical remission combined age, Knosp 0-2 and presurgical GH levels, with a sensitivity of 93.8% and a specificity of 75.0%. This model could be very useful to select candidates to preoperative medical treatment and planning the follow-up.
Entities:
Keywords:
Acromegaly; Pituitary tumour; Predictive model; Surgical remission; Transsphenoidal surgery
Authors: A Abosch; J B Tyrrell; K R Lamborn; L T Hannegan; C B Applebury; C B Wilson Journal: J Clin Endocrinol Metab Date: 1998-10 Impact factor: 5.958
Authors: John A Jane; Robert M Starke; Mohamed A Elzoghby; Davis L Reames; Spencer C Payne; Michael O Thorner; John C Marshall; Edward R Laws; Mary Lee Vance Journal: J Clin Endocrinol Metab Date: 2011-06-29 Impact factor: 5.958
Authors: M Terzolo; S Bossoni; A Alí; M Doga; G Reimondo; G Milani; P Peretti; F Manelli; A Angeli; A Giustina Journal: J Clin Endocrinol Metab Date: 2000-03 Impact factor: 5.958
Authors: A Giustina; P Chanson; M D Bronstein; A Klibanski; S Lamberts; F F Casanueva; P Trainer; E Ghigo; K Ho; S Melmed Journal: J Clin Endocrinol Metab Date: 2010-04-21 Impact factor: 5.958
Authors: Nadia Hameed; Chris G Yedinak; Jessica Brzana; Sakir H Gultekin; Nicholas D Coppa; Aclan Dogan; Johnny B Delashaw; Maria Fleseriu Journal: Pituitary Date: 2013-12 Impact factor: 4.107
Authors: Antonio Mestron; Susan M Webb; Ricardo Astorga; Pedro Benito; Miguel Catala; Sonia Gaztambide; Jose-Manuel Gomez; Irene Halperin; Tomas Lucas-Morante; Basilio Moreno; Gabriel Obiols; Pedro de Pablos; Concha Paramo; Antonio Pico; Elena Torres; Cesar Varela; Jose-Antonio Vazquez; Juana Zamora; Merce Albareda; Montserrat Gilabert Journal: Eur J Endocrinol Date: 2004-10 Impact factor: 6.664
Authors: Tyler Cardinal; Casey Collet; Michelle Wedemeyer; Peter A Singer; Martin Weiss; Gabriel Zada; John D Carmichael Journal: Front Endocrinol (Lausanne) Date: 2021-11-18 Impact factor: 5.555
Authors: Agnieszka Tomasik; Maria Stelmachowska-Banaś; Maria Maksymowicz; Izabella Czajka-Oraniec; Dorota Raczkiewicz; Grzegorz Zieliński; Jacek Kunicki; Wojciech Zgliczyński Journal: Front Endocrinol (Lausanne) Date: 2022-09-16 Impact factor: 6.055